Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

35 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
[Stabilized NADH (ENADA) improves jet lag-induced cognitive performance deficit].
Birkmayer GD, Kay GG, VĂ¼rre E. Birkmayer GD, et al. Among authors: kay gg. Wien Med Wochenschr. 2002;152(17-18):450-4. doi: 10.1046/j.1563-258x.2002.02072.x. Wien Med Wochenschr. 2002. PMID: 12385067 Clinical Trial. German.
Evaluation of cognitive function in healthy older subjects treated with fesoterodine.
Kay GG, Maruff P, Scholfield D, Malhotra B, Whelan L, Darekar A, Martire DL. Kay GG, et al. Postgrad Med. 2012 May;124(3):7-15. doi: 10.3810/pgm.2012.05.2543. Postgrad Med. 2012. PMID: 22691894 Clinical Trial.
Treatment of Alzheimer's disease with stabilized oral nicotinamide adenine dinucleotide: a randomized, double-blind study.
Demarin V, Podobnik SS, Storga-Tomic D, Kay G. Demarin V, et al. Drugs Exp Clin Res. 2004;30(1):27-33. Drugs Exp Clin Res. 2004. PMID: 15134388 Clinical Trial.
Next-day residual effects of flibanserin on simulated driving performance in premenopausal women.
Kay GG, Hochadel T, Sicard E, Natarajan KK, Kim NN. Kay GG, et al. Hum Psychopharmacol. 2017 Jul;32(4):e2603. doi: 10.1002/hup.2603. Epub 2017 May 31. Hum Psychopharmacol. 2017. PMID: 28568608 Free PMC article. Clinical Trial.
Next-day residual effects of gabapentin, diphenhydramine, and triazolam on simulated driving performance in healthy volunteers: a phase 3, randomized, double-blind, placebo-controlled, crossover trial.
Kay GG, Schwartz HI, Wingertzahn MA, Jayawardena S, Rosenberg RP. Kay GG, et al. Hum Psychopharmacol. 2016 May;31(3):217-26. doi: 10.1002/hup.2530. Epub 2016 Mar 28. Hum Psychopharmacol. 2016. PMID: 27018419 Clinical Trial.
A randomized, crossover, placebo-controlled clinical trial to assess the sensitivity of the CRCDS Mini-Sim to the next-day residual effects of zopiclone.
Simen AA, Gargano C, Cha JH, Drexel M, Bautmans A, Heirman I, Laethem T, Hochadel T, Gheyle L, Bleys K, Beals C, Stoch A, Kay GG, Struyk A. Simen AA, et al. Among authors: kay gg. Ther Adv Drug Saf. 2015 Jun;6(3):86-97. doi: 10.1177/2042098615579314. Ther Adv Drug Saf. 2015. PMID: 26240742 Free PMC article.
Effects of armodafinil on simulated driving and self-report measures in obstructive sleep apnea patients prior to treatment with continuous positive airway pressure.
Kay GG, Feldman N. Kay GG, et al. J Clin Sleep Med. 2013 May 15;9(5):445-54. doi: 10.5664/jcsm.2662. J Clin Sleep Med. 2013. PMID: 23674935 Free PMC article. Clinical Trial.
Simulated driving changes in young adults with ADHD receiving mixed amphetamine salts extended release and atomoxetine.
Kay GG, Michaels MA, Pakull B. Kay GG, et al. J Atten Disord. 2009 Jan;12(4):316-29. doi: 10.1177/1087054708322986. Epub 2008 Sep 24. J Atten Disord. 2009. PMID: 18815438
Antimuscarinic drugs for overactive bladder and their potential effects on cognitive function in older patients.
Kay GG, Abou-Donia MB, Messer WS Jr, Murphy DG, Tsao JW, Ouslander JG. Kay GG, et al. J Am Geriatr Soc. 2005 Dec;53(12):2195-201. doi: 10.1111/j.1532-5415.2005.00537.x. J Am Geriatr Soc. 2005. PMID: 16398909 Review.
Pharmacodynamic effects of darifenacin, a muscarinic M selective receptor antagonist for the treatment of overactive bladder, in healthy volunteers.
Kay GG, Wesnes KA. Kay GG, et al. BJU Int. 2005 Nov;96(7):1055-62. doi: 10.1111/j.1464-410X.2005.05745.x. BJU Int. 2005. PMID: 16225528 Clinical Trial.
35 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page